Eric Kauffman, MD

Eric Kauffman, MD

Roswell Park Cancer Institute
Assistant Professor of Oncology
Department of Urology
Department of Cancer Genetics
University at Buffalo, State University of New York
Clinical Assistant Professor of Urology

Dr. Kauffman was appointed to the faculty at Roswell Park Cancer Institute (RPCI) in 2012. He serves in the Department of Urology and in the Department of Cancer Genetics. Dr. Kauffman attended the Pritzker School of Medicine at the University of Chicago, IL, where he earned his medical degree (2004) and was awarded a Howard Hughes Medical Institute fellowship for molecular research in prostate cancer (2001-2002). He subsequently completed his internship in General Surgery (2006) and residency in Urology (2010) at New York Presbyterian Hospital of Weill Medical College, Cornell University in New York, NY. He completed a clinical and research fellowship in Urologic Oncology at the National Cancer Institute of the National Institutes of Health in Bethesda, MD in 2012. 

Dr. Kauffman specializes in the care of patients with kidney and prostate cancers and provides expertise in both robot-assisted and open operative approaches, including partial or radical nephrectomy and radical prostatectomy. His research interests include active surveillance as a primary management option for patients with low-risk kidney cancers, and the molecular characterization of early metastatic potential in kidney and prostate cancers, including molecular marker discovery and elucidation of signaling pathways for therapeutic targeting. 

Dr. Kauffman is a member of the American Urological Association and the Society of Urologic Oncology. 

Dr. Kauffman has authored and co-authored several peer-reviewed publications, book chapters and abstracts on genitourinary oncology topics.

Special Interests: 
Active surveillance management of patients with small kidney tumors
Metastatic biology/potential of small kidney tumors
Molecular markers for kidney and prostate cancer patient risk stratification
Genetics and molecular pathways for therapeutic targeting in kidney and prostate cancers
Fellowship: 
2010-2012 - Urologic Oncology - National Cancer Institute, National Institutes of Health, Bethesda, MD
Residency: 
2006-2010 - Urology - New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY
2004-2006 - General Surgery - New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY
Education and Training: 
2004 - MD - Pritzker School of Medicine, University of Chicago, Chicago, IL
Professional Memberships: 
2012-present - Society of Urologic Oncology
2005-present - American Urological Association